欧洲药品管理局关于首次人体临床试验的指南及其对药物研发的影响。 - Suppr

The EMEA guideline on first-in-human clinical trials and its impact on pharmaceutical development.

作者信息

Milton Mark N, Horvath Christopher J

机构信息

Tempo Pharmaceuticals, Cambridge, Massachusetts 02142, USA.

出版信息

Toxicol Pathol. 2009 Apr;37(3):363-71. doi: 10.1177/0192623309332997. Epub 2009 Feb 26.

DOI:10.1177/0192623309332997

PMID:19246571

Abstract

摘要

相似文献

The EMEA guideline on first-in-human clinical trials and its impact on pharmaceutical development.

Toxicol Pathol. 2009 Apr;37(3):363-71. doi: 10.1177/0192623309332997. Epub 2009 Feb 26.

The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials.

Br J Cancer. 2007 Sep 3;97(5):577-81. doi: 10.1038/sj.bjc.6603925. Epub 2007 Aug 28.

Promoting, improving and accelerating the drug development and approval processes.

Drug News Perspect. 2007 Jan-Feb;20(1):45-55.

Promoting, improving and accelerating the drug development and approval processes.

Drug News Perspect. 2009 Jan-Feb;22(1):30-8. doi: 10.1358/dnp.2009.22.1.1303816.

"Getting the dose right": facts, a blueprint, and encouragements.

Clin Pharmacol Ther. 2007 Jul;82(1):12-4. doi: 10.1038/sj.clpt.6100215.

Cautious welcome for FDA pharmacogenomics guidance.

Nat Biotechnol. 2005 May;23(5):510. doi: 10.1038/nbt0505-510.

FDA and EMEA pool scientific advice.

Nat Biotechnol. 2004 Dec;22(12):1490-1. doi: 10.1038/nbt1204-1490.

The draft FDA guideline on non-inferiority clinical trials: a critical review from European pharmaceutical industry statisticians.

Pharm Stat. 2011 Sep-Oct;10(5):414-9. doi: 10.1002/pst.508. Epub 2011 Sep 19.

[First-in-human clinical trials: comparison of EMEA and FDA guidelines].

Med Clin (Barc). 2009 Jan 17;132(1):30-4. doi: 10.1016/j.medcli.2008.10.022. Epub 2008 Dec 12.

New clinical trials policy at FDA.

Nat Biotechnol. 2006 Sep;24(9):1043. doi: 10.1038/nbt0906-1043. Epub 2006 Sep 1.

引用本文的文献

Sentinel dosing: A proposed algorithm to guide decision making on which cohorts in early phase clinical pharmacology trials should use this approach.

Br J Clin Pharmacol. 2025 Sep;91(9):2705-2710. doi: 10.1002/bcp.70090. Epub 2025 May 15.

A review of dose escalation for FDA-approved products treating solid tumors and hematological malignancies in first-in-human trials.

Clin Transl Oncol. 2024 Sep;26(9):2116-2125. doi: 10.1007/s12094-024-03451-2. Epub 2024 Apr 1.

Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study.

BMC Med. 2023 Jul 5;21(1):246. doi: 10.1186/s12916-023-02937-0.

Pharmacokinetic/pharmacodynamic modeling for dose selection for the first-in-human trial of the activated Factor XII inhibitor garadacimab (CSL312).

Clin Transl Sci. 2022 Mar;15(3):709-720. doi: 10.1111/cts.13192. Epub 2021 Dec 8.

Clinical pharmacology applications in clinical drug development and clinical care: A focus on Saudi Arabia.

Saudi Pharm J. 2020 Oct;28(10):1217-1227. doi: 10.1016/j.jsps.2020.08.012. Epub 2020 Aug 21.

Determination of the starting dose in the first-in-human clinical trials with monoclonal antibodies: a systematic review of papers published between 1990 and 2013.

Drug Des Devel Ther. 2016 Dec 8;10:4005-4016. doi: 10.2147/DDDT.S121520. eCollection 2016.

Implications of the BIA-102474-101 study for review of first-into-human clinical trials.

Br J Clin Pharmacol. 2016 Apr;81(4):582-6. doi: 10.1111/bcp.12920.

Choice of Starting Dose for Biopharmaceuticals in First-in-Human Phase I Cancer Clinical Trials.

Oncologist. 2015 Jun;20(6):653-9. doi: 10.1634/theoncologist.2015-0008. Epub 2015 May 11.

Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers.

Drug Des Devel Ther. 2014 Dec 16;9:1-11. doi: 10.2147/DDDT.S72572. eCollection 2015.

Challenges and approaches for the development of safer immunomodulatory biologics.

Nat Rev Drug Discov. 2013 Apr;12(4):306-24. doi: 10.1038/nrd3974.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

The EMEA guideline on first-in-human clinical trials and its impact on pharmaceutical development.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献